Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Morpholine | HCID 8083 | — |
| Reactant | Triethylamine | HCID 8471 | — |
| Reactant | HCID 86646041 | HCID 86646041 | — |
| Solvent | Tetrahydrofuran | HCID 8028 | — |
| Product | HCID 59506920 | HCID 59506920 | 55% |
Reaction Steps
To a solution of N-[3-({2-[(chloroacetyl)amino][1,3]thiazolo[5,4-b]pyridin-5-yl}oxy)-4-methylphenyl]-3-(1-cyano-1-methylethyl)benzamide (304 mg, 0.584 mmol) produced in Example C15(i) in tetrahydrofuran (5 mL) were added morpholine (78.8 μL, 0.901 mmol) and triethylamine (125 μL, 0.901 mmol), and the mixture was stirred at 60° C. for 4 hr. The title compound (141 mg, 55%) was obtained as white crystals by operation in the same manner as in Example C88. The present compound was recrystallized from ethyl acetate and tetrahydrofuran.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08344135B2 |
|---|
| Source dataset | uspto-grants-2013_01 |
|---|
| ORD ID | ord-922e4dfef5f44d8ba90dde26c4d73ebf |
|---|
| Source note | uspto-grants-2013_01 |
|---|